Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving <i>EPC2</i> and <i>GULP1</i>
Medulloblastoma is the most common malignant brain tumor in children. Immunotherapy is yet to demonstrate dramatic results in medulloblastoma, one reason being the low rate of mutations creating new antigens in this entity. In tumors with low mutational burden, gene fusions may represent a source of...
Saved in:
Main Authors: | Claudia Paret, Nadine Lehmann, Hannah Bender, Maximilian Sprang, Clemens J. Sommer, Denis Cana, Larissa Seidmann, Arthur Wingerter, Marie A. Neu, Khalifa El Malki, Francesca Alt, Lea Roth, Federico Marini, Malte Ottenhausen, Martin Glaser, Markus Knuf, Alexandra Russo, Joerg Faber |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/ef2a8eb1cda543319a2d2d59080d5609 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DEFINITION OF THE FIELDS OF THE BEST PRACTICES OF EPC (M)-PROJECT MANAGEMENT ON THE BASIS OF THE ANALYSIS OF THE WORLD MARKET
by: A. Laznik
Published: (2017) -
The impact of magnetic resonance imaging spectroscopy parameters on differentiating between paediatric medulloblastoma and ependymoma
by: Nguyen Minh Duc
Published: (2021) -
Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives
by: Marije J. Voskamp, et al.
Published: (2021) -
The SERL Observatory Dataset: Longitudinal Smart Meter Electricity and Gas Data, Survey, EPC and Climate Data for over 13,000 Households in Great Britain
by: Ellen Webborn, et al.
Published: (2021) -
ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells in Vitro Independent of C-Myc Expression
by: Annika Dwucet, et al.
Published: (2021)